XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of stock option activity

Outstanding Options and RSUs

    

    

    

    

Weighted-

    

Weighted-

Average

Shares

Number of

Average

Remaining

Aggregate

Available for

Shares

Exercise

Contractual

Intrinsic

(in thousands, except for contractual life and exercise price)

Grant

Outstanding

Price

Life

Value

(in years)

Balance at December 31, 2022

 

3,263

 

5,300

$

21.11

 

4.84

$

131,385

Additional shares authorized

 

3,500

Options granted

 

(317)

 

317

$

44.17

Options exercised

 

 

(169)

$

13.63

RSUs granted

(5,369)

RSUs forfeited/cancelled

250

Balance at March 31, 2023

 

1,327

 

5,448

$

22.69

4.93

$

199,854

Exercisable at March 31, 2023

 

4,541

$

13.25

4.15

$

194,651

Vested and expected to vest at March 31, 2023

 

5,392

$

22.21

4.89

$

199,545

Restricted stock units

Weighted-

Average

Grant Date

(in thousands, except for grant date fair value)

Shares

Fair Value

Balance at December 31, 2022

6,836

$

57.12

Granted

5,369

$

44.75

Vested

(1,599)

$

57.36

Cancelled/forfeited

(250)

$

51.95

Balance at March 31, 2023

10,356

$

50.75

Summary of stock-based compensation expenses

The following tables present the effect of employee and non-employee stock-based compensation expense on selected statements of operations line items for the three months ended March 31, 2023 and 2022.

Three months ended March 31, 

2023

2022

    

Employee

    

Non-Employee

    

Total

    

Employee

    

Non-Employee

    

Total

(in thousands)

Cost of revenues

$

2,554

$

2

$

2,556

$

1,716

$

$

1,716

Research and development

 

14,315

 

543

 

14,858

 

9,006

 

415

 

9,421

Selling, general and administrative

 

22,959

 

322

 

23,281

 

23,875

 

75

 

23,950

Total

$

39,828

$

867

$

40,695

$

34,597

$

490

$

35,087

Employee stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used in valuation of fair value

Three months ended March 31, 

    

2023

    

    

2022

    

Expected term (years)

 

5.20

6.00

 

5.12

10.00

Expected volatility

 

68.61

%

70.07

%

 

55.91

%

62.30

%

Expected dividend rate

 

0.00

%

 

0.00

%

Risk-free interest rate

 

3.41

%

3.58

%

 

1.62

%

1.78

%